ArticleFrontiers in cellular and infection microbiology2026
DNA damage repair-related gene signatures delineate immune-distinct subtypes and diagnostic cues in tuberculosis.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: DNA damage repair-related genes (DDR-RGs) may shape tuberculosis (TB) pathogenesis, but their molecular characteristics, diagnostic utility, and cellular context remain insufficiently defined. Methods: We integrated multiple GEO transcriptome datasets, identified differentially expressed genes, constructed weighted gene co-expression network analysis modules, and intersected these results with curated DDR-RGs to obtain candidate genes. An ensemble framework of 110 machine-learning model combinations was used to select diagnostic markers, followed by external validation, consensus clustering, immune infiltration analysis, single-cell RNA-seq evaluation, and Comparative Toxicogenomics Database-based compound-association analysis. Results: The integrated training cohort included 134 samples; 94 differentially expressed genes and a 392-gene key module were identified, yielding 25 candidate DDR-RGs. The Ridge + SVM model performed best and selected ETV7, STAT1, FBXO6, and TAP1 as core DDR-RGs, achieving AUCs of 0.991, 0.925, 0.939, and 0.981 in the training and three validation cohorts. Consensus clustering separated TB patients into two DDR-related subtypes, with Cluster 1 enriched in immune-related pathways and characterized by distinct immune-cell infiltration. Single-cell analysis revealed cell-type-specific expression of core DDR-RGs in pulmonary TB, and compound-association analysis identified 35 candidate compounds, including six associated with multiple core genes. Conclusion: These findings characterize DDR-related molecular heterogeneity in TB and support ETV7, STAT1, FBXO6, and TAP1 as candidate diagnostic biomarkers and exploratory candidates for host-directed studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.